The objective of this audit is to assess the effectiveness of the Australian Nuclear Science and Technology Organisation’s management of assets involved in the manufacture, production and distribution of nuclear medicines.

Audit criteria

The ANAO proposes to examine:

  • Does the Australian Nuclear Science and Technology Organisation (ANSTO) have an effective asset management framework for the assets used in nuclear medicine production?
  • Has ANSTO effectively acquired, maintained and disposed of the assets used in nuclear medicine production?
  • Does ANSTO effectively measure, report on and monitor its asset performance?

Contribute to this audit

We anticipate accepting contributions to this audit until Sunday 16 January 2022.

Files must be less than 20 MB.
Allowed file types: txt pdf doc docx.